title: Recovery from anti-recombinant-human-erythropoietin associated pure red cell aplasia in end-stage renal disease patients after renal transplantation.
authors.affiliation: Division of Nephrology, Department of Medicine, Faculty of Medicine, Chulalongkorn University Hospital, Bangkok, Thailand. kearkiat@hotmail.com
authors.forename: Kearkiat
authors.initials: K
authors.lastname: Praditpornsilpa
authors.forename: Somphon
authors.initials: S
authors.lastname: Buranasot
authors.forename: Narudee
authors.initials: N
authors.lastname: Bhokaisuwan
authors.forename: Yingyos
authors.initials: Y
authors.lastname: Avihingsanon
authors.forename: Trairak
authors.initials: T
authors.lastname: Pisitkul
authors.forename: Talerngsak
authors.initials: T
authors.lastname: Kansanabuch
authors.forename: Somchai
authors.initials: S
authors.lastname: Eiam-Ong
authors.forename: Sauwaluck
authors.initials: S
authors.lastname: Chusil
authors.forename: Tanin
authors.initials: T
authors.lastname: Intarakumtornchai
authors.forename: Kriang
authors.initials: K
authors.lastname: Tungsanga
mesh_terms: D000293:Adolescent; D000328:Adult; D000906:Antibodies / Q000502:physiology; D004921:Erythropoietin / Q000009:adverse effects* / Q000276:immunology; D006397:Hematinics / Q000009:adverse effects* / Q000276:immunology; D006801:Humans; D007676:Kidney Failure, Chronic / Q000601:surgery*; D016030:Kidney Transplantation; D008875:Middle Aged; D011994:Recombinant Proteins; D012010:Red-Cell Aplasia, Pure / Q000139:chemically induced* / Q000628:therapy*; D012074:Remission Induction / Q000379:methods
chemical_list: D000906:Antibodies; D006397:Hematinics; D011994:Recombinant Proteins; D004921:Erythropoietin